MechGate: combining mechanism-derived measures of permeation and efflux to screen small molecule drugs targeting Escherichia coli
Abstract
Most antibiotic molecules must cross the cell membrane and escape efflux pumps before hitting their targets. For de novo antibiotic design, very few of the in-silico-generated drug molecules can successfully pass these two steps. Existing evaluations of generated molecules do not separate these steps. Therefore, we introduce MechGate, a mechanism-resolved screening tool evaluating small drug molecules against E. coli, measuring permeation, efflux and antibacterial activity. After SMILES input, five measures are reported side by side: two for permeation via porins, one for permeation via the phospholipid membrane, one for efflux and one for activity. Each measure is read on its own, so a molecule that fails can be traced to the step that stops it. All features are taken from papers that state their mechanism rather than selected by importance ranking. On an external set of marketed antibacterials the measures give a precision of 0.789 to 0.873 against baselines near 0.44, and combining them the way the mechanism predicts raises precision to 0.92. We also find that the four public source libraries are separable from one another using physicochemical features alone; every measure here therefore draws both classes from a single library. All code is open-source and requires no commercial software.
Related
- Regulatory role and mechanism of sRNA24 targeting pqsH in Pseudomonas aeruginosa infection immunity
- Mechanism-Based Discovery of New TRIDs Targeting Ribosome Pockets
- Targeting the SMG9–Wnt/β-catenin axis: A novel mechanism by which ginsenoside Rh2 suppresses triple-negative breast cancer progression
- Computational assay of hERG ion permeation and its modulation by small-molecule compounds
- How a polymer filling enhances the rate and selectivity of colloid permeation across mesopores
BibTeX
@misc{qin2026mechgate,
title = {{MechGate: combining mechanism-derived measures of permeation and efflux to screen small molecule drugs targeting Escherichia coli}},
author = {Lang Qin and Jagath C Rajapakse},
howpublished = {arXiv},
year = {2026},
month = oct,
doi = {10.48550/arxiv.2610.33809},
eprint = {2610.33809},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2610.33809},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - MechGate: combining mechanism-derived measures of permeation and efflux to screen small molecule drugs targeting Escherichia coli
AU - Lang Qin
AU - Jagath C Rajapakse
PY - 2026
DA - 2026/10/24
PB - arXiv
DO - 10.48550/arxiv.2610.33809
UR - https://arxiv.org/abs/2610.33809
AB - Most antibiotic molecules must cross the cell membrane and escape efflux pumps before hitting their targets. For de novo antibiotic design, very few of the in-silico-generated drug molecules can successfully pass these two steps. Existing evaluations of generated molecules do not separate these steps. Therefore, we introduce MechGate, a mechanism-resolved screening tool evaluating small drug molecules against E. coli, measuring permeation, efflux and antibacterial activity. After SMILES input, five measures are reported side by side: two for permeation via porins, one for permeation via the phospholipid membrane, one for efflux and one for activity. Each measure is read on its own, so a molecule that fails can be traced to the step that stops it. All features are taken from papers that state their mechanism rather than selected by importance ranking. On an external set of marketed antibacterials the measures give a precision of 0.789 to 0.873 against baselines near 0.44, and combining them the way the mechanism predicts raises precision to 0.92. We also find that the four public source libraries are separable from one another using physicochemical features alone; every measure here therefore draws both classes from a single library. All code is open-source and requires no commercial software.
ER -